多瑞医药(301075.SZ)：前三季净亏损7972.77万元
DUO RUI PHARMADUO RUI PHARMA(SZ:301075) Ge Long Hui A P P·2025-10-23 08:59

Core Viewpoint - Duori Pharmaceutical (301075.SZ) reported a significant decline in revenue and an increase in net losses for the third quarter of the year [1] Financial Performance - The company recorded a revenue of 137 million yuan for the first three quarters, representing a year-on-year decrease of 43.07% [1] - The net loss for the period amounted to 79.72 million yuan, with a non-recurring net loss of 84.95 million yuan [1] - Basic earnings per share were reported at -1.0064 yuan [1]